Andrew Silver

Mr. Andrew J.
Silver is a Chief Financial & Accounting Officer at CRISPR Therapeutics AG.
Mr. Silver was previously employed as a Managing Director-Basic Industrials Group by Houlihan Lokey Capital, Inc. and a Senior Manager-Assurance Services by Ernst & Young LLP.
He received his undergraduate degree from Boston College Carroll School of Management and a graduate degree from the University of Connecticut School of Business.